Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.64 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.64 |
| ▸ | NPFFR1 | Q9GZQ6 | 2/20 | 0.64 |
| ▸ | NPFFR2 | Q9Y5X5 | 2/20 | 0.64 |
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.52 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.52 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.50 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.49 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9540952 | 0.89 | NTSR1 (0.65) | NTSR1NTSR2 | |
| SCHEMBL9540901 | 0.88 | NTSR1 (0.64) | NTSR1NTSR2 | |
| SCHEMBL32664435 | 0.87 | NTSR2 (0.58) | OPRM1OPRD1NPFFR1NPFFR2NTSR1 | |
| SCHEMBL29769812 | 0.85 | EPHA2 (0.56) | OPRM1OPRD1NMUR2NMUR1EPHA2 | |
| SCHEMBL31676699 | 0.85 | OPRM1 (0.57) | OPRM1OPRD1NPFFR1NPFFR2NTSR1 | |
| SCHEMBL29629297 | 0.84 | EPHA2 (0.51) | OPRM1OPRD1NMUR2NMUR1EPHA2 | |
| SCHEMBL31410880 | 0.84 | OPRM1 (0.58) | OPRM1OPRD1NPFFR1NPFFR2NMUR2 | |
| SCHEMBL8382316 | 0.84 | OPRM1 (0.48) | OPRM1OPRD1NPFFR1NPFFR2NMUR2 | |
| SCHEMBL29496918 | 0.84 | SLC6A2 (0.57) | OPRM1OPRD1NMUR2NMUR1EPHA2 | |
| SCHEMBL29496917 | 0.84 | SLC6A2 (0.57) | OPRM1OPRD1NMUR2NMUR1EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993000359-A1 | MODIFIED PEPTIDES TRANSPORTABLE INTO THE CENTRAL NERVOUS SYSTEM | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-01-07 | — | — | WO | disclosed |